Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SPDR S&P Oil & Gas Exploration & Production ETF
XOP
5
VanEck Oil Services ETF
OIH
No Data
NYSE Content Update: PointFive Raises $60 Million to Redefine Efficiency
Express News | AIM ImmunoTech Reports Positive Mid-Year Interim Clinical Progress From Phase 2 Study Evaluating Ampligen® (Rintatolimod) in Combination With Astrazeneca’s Imfinzi® (Durvalumab) for the Treatment of Pancreatic Cancer
At a Glance: Stocks Gapping Down Premarket
Bernstein Sees Upside Potential in AstraZeneca's Non-oncology Pipeline After Fireside Chat
AstraZeneca's Ultomiris Reduces Proteinuria in Kidney Study
Express News | AstraZeneca CEO: Group may pause new drug launches in Europe